Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 454.00
Bid: 454.00
Ask: 457.00
Change: -8.50 (-1.84%)
Spread: 3.00 (0.661%)
Open: 464.00
High: 473.00
Low: 454.00
Prev. Close: 462.50
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Treatt (TET): Sweet upgrades

19 May 2021 07:00

Edison Investment Research Limited Treatt (TET): Sweet upgrades 19-May-2021 / 07:00 GMT/BST


 

London, UK, 19 May 2021

 

Treatt (TET): Sweet upgrades

Treatt has once again demonstrated the strength of its business model, with another excellent set of results, and yet another upgrade to guidance. The performance continues to be testament to the management and culture of the business, which has been transformed under CEO Daemmon Reeve's nine years at the helm. Both sales and profit performance are impressive, and we once again raise our forecasts, as the 'healthier' categories continue to outperform. The relocation of the UK business is under way, and we expect the business to continue to perform well once the new UK capacity comes on stream.

 

Treatt trades at 40.7x and 28.1x FY21 P/E and EV/EBITDA, representing premiums of c 30% and c 40% respectively to its peers. We note that the current share price is discounting medium-term sales growth of 5.0%, falling to 2.5% in perpetuity, with a WACC of 5.7% and a terminal EBIT margin of 20.0%. We forecast net debt at end FY21, moving to a net cash position thereafter, and hence expect a significant uplift in the dividend in FY21.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Sara Welford +44 (0)20 3077 5700 consumer@edisongroup.com

Russell Pointon +44 (0)20 3077 5700 consumer@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1198024 19-May-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
9th Dec 200910:46 amRNSDirector Declaration
7th Dec 20097:00 amRNSFinal Results
4th Dec 20094:02 pmRNSBoard Appointment
24th Nov 200910:29 amRNSHolding(s) in Company
4th Nov 200912:53 pmRNSDirectorate Change
28th Oct 200910:35 amRNSTotal Voting Rights
8th Oct 20094:41 pmRNSClarification of PDMR Shareholding
8th Oct 200910:40 amRNSDirector/PDMR Shareholding
8th Oct 200910:35 amRNSDirector/PDMR Shareholding
30th Sep 200910:00 amRNSTotal Voting Rights
28th Sep 200911:51 amRNSDirector/PDMR Shareholding
28th Sep 200911:48 amRNSDirector/PDMR Shareholding
4th Sep 200912:27 pmRNSDirector/PDMR Shareholding
4th Sep 200912:24 pmRNSDirector/PDMR Shareholding
4th Sep 200912:19 pmRNSDirector/PDMR Shareholding
20th Aug 200911:37 amRNSHolding(s) in Company
31st Jul 200910:48 amRNSTotal Voting Rights
29th Jul 200912:03 pmRNSDirector/PDMR Shareholding
29th Jul 200911:59 amRNSDirector/PDMR Shareholding
29th Jul 200911:54 amRNSDirector/PDMR Shareholding
21st Jul 20099:59 amRNSInterim Management Statement
1st Jun 20099:47 amRNSHolding(s) in Company
26th May 20097:00 amRNSInterim Results
9th Mar 20091:07 pmRNSDirector/PDMR Shareholding
9th Mar 200912:39 pmRNSDirector/PDMR Shareholding
13th Feb 200910:28 amRNSInterim Management Statement
22nd Dec 20089:46 amRNSAnnual Information Update
15th Dec 20087:00 amRNSPreliminary Results
31st Oct 200810:41 amRNSTotal Voting Rights
14th Oct 20082:01 pmRNSDirector/PDMR Shareholding
7th Oct 20081:37 pmRNSDirector/PDMR Shareholding
7th Oct 20081:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20084:33 pmRNSDirector/PDMR Shareholding
30th Sep 20084:04 pmRNSTotal Voting Rights
30th Sep 20083:40 pmRNSDirectorate Change
23rd Sep 20083:05 pmRNSDirector/PDMR Shareholding
27th May 20087:00 amRNSInterim Results
19th May 20085:25 pmRNSHolding(s) in Company
10th Apr 20085:25 pmRNSTrading Statement
11th Mar 20085:12 pmRNSDirector/PDMR Shareholding
11th Mar 20085:09 pmRNSDirector/PDMR Shareholding
29th Feb 20089:12 amRNSTotal Voting Rights
15th Feb 20084:27 pmRNSInterim Management Statement
12th Feb 20086:33 pmRNSDirector/PDMR Shareholding
20th Dec 20071:51 pmRNSAnnual Information Update
19th Dec 200711:10 amRNSTotal Voting Rights
10th Dec 20077:00 amRNSFinal Results
5th Sep 200711:56 amRNSDirector/PDMR Shareholding
3rd Sep 20076:09 pmRNSHolding(s) in Company
3rd Sep 20075:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.